Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
21 results
  1. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... GD, et al.: Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. ...
  2. Carcinoma of Unknown Primary Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65811
    ... bleomycin, and cisplatin; however, some patients received a doxorubicin-containing ... A paclitaxel-based combination yielded a 48% response rate in ...
  3. Systemic Therapy - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82144
    ... The studies investigated a variety of combination chemotherapy regimens ... taxanes (paclitaxel and docetaxel) and from 2003 onwards trials investigated ...
  4. Appendices - Early and locally advanced breast cancer: diagnosis and management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK541684
    ... as less than 60% agreement 7 Taxane-containing regimens may reduce cardiac ... with doxorubicin 0 Discarded as less than 60% agreement 10 ...
  5. Articles Excluded at Full-Text Screening by Reason - Progression-Free Survival: What Does It Mean for Psychological ... 
    https://www.ncbi.nlm.nih.gov/books/NBK137765
    ... PubMed : 22234633 ] Refid: 1628. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results ...
  6. Urethral Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65918
    ... contains the following:[ 1 , 4 - 7 ] Methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC). Paclitaxel. Carboplatin. Ifosfamide, with occasional complete responses. Chemotherapy has ...
  7. Results - Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK310449
    ... an additional two cycles of the first chemotherapy regimen; from 2003-2007, chemotherapy with paclitaxel, gemcitabine, and cisplatin for two cycles, followed by ...
  8. Nausea and Vomiting Related to Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66056
    ... Ipilimumab. - Ixabepilone. - Methotrexate. - Mitomycin. - Mitoxantrone. - Nab-paclitaxel. - Necitumumab. - Paclitaxel. - Panitumumab. - Pegylated liposomal doxorubicin. - Pemetrexed. - Pertuzumab. - Temsirolimus. - Topotecan. - Trastuzumab-emtansine. Minimal risk: ...
  9. Small Cell Lung Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65909
    ... window Standard treatment Etoposide + cisplatin Etoposide + carboplatin Other regimens Cisplatin + irinotecan Ifosfamide + cisplatin + etoposide Cyclophosphamide + doxorubicin + etoposide Cyclophosphamide + doxorubicin + etoposide + vincristine Cyclophosphamide + etoposide + vincristine ...
  10. Prioritization and Selection of Harms for Inclusion in Systematic Reviews - Methods Guide for Effectiveness and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK519367
    ... chemotherapeutic agents (e.g., mitomycin C [MMC], apaziquone, paclitaxel, gemcitabine, thiotepa, valrubicin, doxorubicin, epirubicin), bacillus Calmette-Guérin (BCG), or interferon immunotherapy ...
previous · 1 · 2 · 3 · next